Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomized, dose-escalation phase 1 study

Por Issa, Jean-Pierre J., Roboz, Gail, Rizzieri, David, Jabbour, Elias, Stock, Wendy, O’Connell, Casey, Yee, Karen, Tibes, Raoul, Griffiths, Elizabeth A., Walsh, Katherine, Daver, Naval, Chung, Woonbok, Naim, Sue, Taverna, Pietro, Oganesian, Aram, Hao, Yong, Lowder, James N., Azab, Mohammad, Kantarjian, Hagop
Publicado no Lancet Oncol (2015)